AMERICAN SHARED HOSPITAL SERVICES Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest
AMERICAN SHARED HOSPITAL SERVICES (AMS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest of $22.00 thousand for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest · last filed 2013-08-14
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2013-06-30 was $8.00K.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2013-03-31 was $14.00K.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2012-12-31 was -$228.00K.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for the quarter ending 2012-09-30 was -$52.00K.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2012 was -$280.00K.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2011 was $0.00.
- AMERICAN SHARED HOSPITAL SERVICES other comprehensive income (loss), net of tax, portion attributable to noncontrolling interest for fiscal 2010 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2013-06-30 | $8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $22.00K 10-Q · filed 2013-08-14 | -$206.00K derived: sum of 3 quarters · filed 2013-08-14 | -$258.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | $14.00K 10-Q · filed 2013-05-15 | -$214.00K derived: sum of 2 quarters · filed 2013-05-15 | -$266.00K derived: sum of 3 quarters · filed 2013-05-15 | -$266.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-12-31 | -$228.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | -$280.00K derived: sum of 2 quarters · filed 2013-03-29 | -$280.00K derived: sum of 3 quarters · filed 2013-08-14 | -$280.00K 10-K · filed 2013-03-29 |
| 2012-09-30 | -$52.00K 10-Q · filed 2012-11-14 | -$52.00K derived: sum of 2 quarters · filed 2013-08-14 | -$52.00K 10-Q · filed 2012-11-14 | -$52.00K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | $0.00 derived: sum of 3 quarters · filed 2013-08-14 | $0.00 derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | $0.00 derived: sum of 2 quarters · filed 2013-05-15 | $0.00 derived: sum of 3 quarters · filed 2013-05-15 | |
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $0.00 derived: sum of 2 quarters · filed 2013-03-29 | $0.00 10-K · filed 2013-03-29 | |
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||
| 2010-12-31 | $0.00 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |